Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease.

Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease.

Neuroscience letters (2002-12-25)

Takashi Abe, Chiaki Isobe, Takahiko Murata, Chigumi Sato, Hideo Tohgi

ABSTRACT

In order to investigate the possible role of oxidative RNA damage in the pathogenesis of Parkinson's disease (PD), the concentrations of the oxidative stress marker 8-hydroxyguanosine (8-OHG) were measured in the cerebrospinal fluid (CSF) and the serum of patients with PD and control subjects. The concentration of 8-OHG in CSF in PD patients was approximately three-fold that in controls (P < 0.001). The concentration of 8-OHG in CSF decreased significantly with the duration of disease (r(s) = -0.46, P < 0.05). However, the concentration of 8-OHG in serum was not significantly altered in PD patients compared to that in controls. In addition, the concentration of 8-OHG in CSF showed no correlation with that in serum in both the controls and PD patients suggesting that the 8-OHG concentrations in the CSF do not reflect those in serum and may be probably reflect those in brain tissue. These in vivo findings suggest a possible role of 8-OHG and increased oxidative RNA damage in the early stage of the development of PD.

MATERIALS

Product Number

Brand

Product Description

463728

Sigma-Aldrich

Manganese, powder, ≥99.9% trace metals basis

49603

Supelco

L-Cystine, certified reference material, TraceCERT^®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

577987

Sigma-Aldrich

Molybdenum, nanopowder, <100 nm particle size (TEM), 99.8% trace metals basis

499552

Sigma-Aldrich

Zinc preparation, 5 g/dL Zn²⁺ in THF, highly reactive Rieke^®metal

349208

Sigma-Aldrich

Copper, foil, thickness 0.025 mm, 99.98% trace metals basis

369489

Sigma-Aldrich

Titanium, foil, thickness 2.0 mm, 99.7% trace metals basis

349216

Sigma-Aldrich

Copper, wire, diam. 1.0 mm, ≥99.9%

357626

Sigma-Aldrich

Nickel, wire, diam. 0.5 mm, ≥99.9% trace metals basis

499579

Sigma-Aldrich

Magnesium preparation, Highly Reactive Rieke^® Metal, suspension, 2.5 g in THF

326429

Sigma-Aldrich

Copper, wire, diam. 0.25 mm, 99.999% trace metals basis

520373

Sigma-Aldrich

Tin, powder, 10 μm, 99% trace metals basis

326410

Sigma-Aldrich

Copper, wire, diam. 0.64 mm, 99.995% trace metals basis

349224

Sigma-Aldrich

Copper, wire, diam. 2.0 mm, 99.999% trace metals basis

326380

Sigma-Aldrich

Cobalt, foil, thickness 0.1 mm, ≥99.99%

266515

Sigma-Aldrich

Aluminum, ≤30 μm, spherical powder, ≥99%

266558

Sigma-Aldrich

Aluminum, wire, diam. 1.0 mm, 99.999% trace metals basis

518573

Sigma-Aldrich

Aluminum, granular, <1 mm, 99.7% trace metals basis

433705

Sigma-Aldrich

Aluminum, evaporation slug, diam. × L 6.3 mm × 6.3 mm, 99.999% trace metals basis

326887

Sigma-Aldrich

Aluminum, wire, diam. 0.58 mm, ≥99.99% trace metals basis

326941

Sigma-Aldrich

Aluminum, pellets, 3-8 mesh, ≥99.999% trace metals basis

576883

Sigma-Aldrich

Tin, nanopowder, <150 nm particle size (SEM), ≥99% trace metals basis

578002

Sigma-Aldrich

Zinc, nanopowder, 40-60 nm avg. part. size, ≥99% trace metals basis

577995

Sigma-Aldrich

Nickel, nanopowder, <100 nm avg. part. size, ≥99% trace metals basis

C3300000

Cystine, European Pharmacopoeia (EP) Reference Standard

734365

Sigma-Aldrich

Magnesium, wire, 127 μm diameter, 99.9% trace metals basis

C8755

Sigma-Aldrich

L-Cystine, ≥98% (TLC), crystalline

IRMM523B

Aluminum, IRMM^®, certified reference material, 1.0 mm foil

31653

Sigma-Aldrich

Zinc, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.9%, granular

14509

Sigma-Aldrich

Tin, ≥99%, powder

IRMM523C

Aluminum, IRMM^®, certified reference material, 1.0 mm wire